Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.
Jul 19, 2022
0
33
Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system. Scientists at Scripps Research and collaborators have now uncovered how our innate immune system—the ...
Jul 8, 2022
0
70
Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).
Jul 1, 2022
0
3
While multiple effective COVID-19 vaccines were developed with astonishing speed, it has been more than 40 years since University of Rochester alumnus Michael Gottlieb, M.D., first described the disease that became known ...
May 27, 2022
0
13
About 36 million people have died from AIDS-related illnesses and approximately 38 million people globally are living with HIV.
May 25, 2022
0
26
A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system. The virus, ...
May 11, 2022
0
52
Antiretroviral therapy has made HIV a manageable condition, but it does not eliminate the virus from the body—and most regimens are expensive and require a pill every day, for the rest of the patient's life.
Apr 19, 2022
0
28
The infection of human immunology viruses (HIV) occurs by integrating its genome into infected cells to enter an inactive state of reversible latency that evades anti-retroviral therapy. The capacity to sequence such a provirus ...
Scientists at Northwestern Medicine are using new advances in CRISPR gene-editing technology to uncover new biology that could lead to longer-lasting treatments and new therapeutic strategies for Human Immunodeficiency Virus ...
Apr 1, 2022
2
326
